Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
about
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppressionTargeting the epigenome in lung cancer: expanding approaches to epigenetic therapySurfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review)An overview of epigenetics and chemopreventionhMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesisLung cancer. 1: prevention of lung cancerGenetic alteration and gene expression modulation during cancer progressionThe molecular basis of lung cancer: molecular abnormalities and therapeutic implicationsPreneoplastic lesions of the lungEpigenetics and airways diseaseEpigenetics in non-small cell lung cancer: from basics to therapeuticsInduced pluripotent stem cell technology for dissecting the cancer epigenomeCancer heterogeneity--a multifaceted viewEpigenetics of lung cancerGenomic impact of cigarette smoke, with application to three smoking-related diseasesEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerInactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samplesHigh risk of tobacco-related cancers in CDKN2A mutation-positive melanoma familiesBiomarkers in cancer staging, prognosis and treatment selectionLung cancer epigenetics: emerging biomarkersThe epigenomics of cancerGlobal methylation profiling of lung cancer identifies novel methylated genesMethylation mattersStrain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytolueneDNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateSome molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of originSilencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinomaRole of cell cycle regulators in lung carcinogenesisPulmonary adenocarcinoma: a renewed entity in 2011Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylationDose- and time- effect responses of DNA methylation and histone H3K9 acetylation changes induced by traffic-related air pollutionBiomarkers of genome instability and cancer epigenetics.The role of DNA methylation as biomarkers in the clinical management of lung cancer.Emerging molecular markers of cancer.PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.Sequence-specific DNA binding activity of RNA helicase A to the p16INK4a promoter.DNA methylation, methyltransferases, and cancer.Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
P2860
Q24291194-1B694927-808F-41D1-8B02-BF1E17F169CAQ24609974-0B8406A7-F145-488E-8CDE-E625AEC2E47FQ24617128-851E7757-3AF9-4BE2-BA25-1ED91A211D15Q24623823-399D27DF-40C0-4FEF-B05D-87F93F0F06F8Q24670424-FDCDEDF7-D3E1-4706-B286-9100FDE46840Q24678926-B82136B4-23C8-4801-BCBA-98CB60BA7B58Q24798750-F52B043A-A56D-4D03-BF19-DBD8619C6FBAQ24802445-DAAE1DA9-7DEA-492C-BF5C-8D9A3168C030Q24807204-807BC832-8C12-4D54-955A-C1C70280A894Q25256981-A4B2E198-D68E-404B-B371-D5FECC799EE3Q26749113-A334A8F9-29A6-4531-B184-6115665AF64FQ26801711-E369E913-DAD0-4695-835E-6F7F90FCC79FQ26829228-A8962C0C-881B-4519-96C9-E5EAE4A8286FQ26996766-E17AD8CA-1AA5-4FAA-B215-5CEF9D5E5521Q27027763-4E955D41-6E8F-4088-9F74-5A4CDD71C30FQ28087759-8248B1F7-2EB3-4A31-B9C5-CD50059396C5Q28183803-6E23350D-5E7B-4F26-927A-5E124D72A70DQ28242124-B72D8D7E-F9F2-4E6D-B82B-DADED83E41C4Q28278305-93A8E772-2EF0-455A-B56B-A0494D337916Q28285049-7F2557BF-B367-4F55-B340-21BE7C8F817EQ28289975-49C5147D-029E-4329-A087-3BD5D3E5F3B9Q28360366-0165787C-4C34-48EE-A743-946E089BB2D5Q28364163-585F0AF2-C387-4D40-B541-429C5CF855B2Q28375629-C5287500-7B05-40AC-873B-259847F84D3DQ28386334-1D6CFB08-D9FB-4C31-85D2-1371EE137B84Q28390768-BFF65946-D0D3-4F3B-B7FC-DAFD7699B366Q28392002-1847A746-CDAC-416A-AF3B-7B1E0641EC07Q28394676-BCC7C019-BF81-4FA4-803C-B646EAA885A2Q28395348-DFDAE9DF-E940-4EDF-A6B0-C149C44CE4C5Q28476454-0FA0CB18-C1A8-47EE-B113-4D6F17C2F338Q29248414-E0E8E404-FF96-426E-8565-A646E2408603Q30248745-1E14AE3F-B14E-4F99-8021-1407473B6396Q30317739-FCE812EB-6C1A-43FF-9C38-1C29C3EA7A79Q30330271-655D91CB-8DC4-45F4-8573-E8BC71391902Q30476274-7CC3B168-BE67-4811-8599-E336D6BDF62CQ30912629-3ED8E357-9301-4228-A712-34FE6C43F0D2Q30945379-3FE252D1-EDC9-46AE-B845-54D548F879E8Q30993657-7A209079-FA61-47B0-9688-13C0659D42B1Q33509293-16B462D8-155C-4FC7-9AD2-9CFD455A4607Q33531781-95966669-4946-4288-9ED5-0B3744A2DA69
P2860
Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Aberrant methylation of p16(IN ...... biomarker for early diagnosis
@ast
Aberrant methylation of p16(IN ...... biomarker for early diagnosis
@en
type
label
Aberrant methylation of p16(IN ...... biomarker for early diagnosis
@ast
Aberrant methylation of p16(IN ...... biomarker for early diagnosis
@en
prefLabel
Aberrant methylation of p16(IN ...... biomarker for early diagnosis
@ast
Aberrant methylation of p16(IN ...... biomarker for early diagnosis
@en
P2093
P2860
P356
P1476
Aberrant methylation of p16(IN ...... biomarker for early diagnosis
@en
P2093
E Gabrielson
G Saccomanno
J G Herman
K J Nikula
S A Belinsky
S B Baylin
W A Palmisano
P2860
P304
11891-11896
P356
10.1073/PNAS.95.20.11891
P407
P577
1998-09-01T00:00:00Z